Argon Beam Coagulator as an Adjunct to Surgery in the Treatment of Drug-Resistant Ventricular Tachycardia. Basic Experiments and Clinical Application.
10.4326/jjcvs.21.525
- VernacularTitle:薬剤抵抗性心室頻拍に対する外科治療の補助手段としてのＡｒｇｏｎ ｂｅａｍ ｃｏａｇｕｌａｔｏｒ 基礎実験および臨床応用
- Author:
Takashi ADACHI
;
Masayoshi YOKOYAMA
;
Toshinari ITAOKA
;
Takamasa ONUKI
;
Mayumi SHIMIZU
;
Sumio NITTA
- Publication Type:Journal Article
- Keywords:
Argon beam coagulator
- From:Japanese Journal of Cardiovascular Surgery
1992;21(6):525-528
- CountryJapan
- Language:Japanese
-
Abstract:
Surgery and cryoablation have been the preferred method for treating drug resistant ventricular tachycardia (VT). Cryoablation, the therapeutic usefulness of which has been documented in many reported studies, is nevertheless not free from technical difficulaties. The advent of Bard® System 6000 Argon beam coagulator (ABC) as a new procedure alternative to cryoablation offered us a hope for solving problems with conventionally used techniques. Preliminary experiments with this device on dog myocardium permitted us to determine therapeutically adequate irradiation time and depth of cauterization and to locate an optimum area of myocardium to be coagulated. Based on these experiences, an attempt was made to use ABC as an adjunct to surgery in the surgical treatment of 4 patients with monofocal non-ischemic VT. In 1 of these 4 patients, VT disappeared postoperatively, making use of antiarrythmia drugs quite unnecessary, while in the remaining 3, a marked diminution of ventricular arrhythmia with a consequent reduction of drug dosage was achieved, use of the device thus being judged to be beneficial. These results led to the conclusion that ABC will provide a valuable adjunct to operation in selected cases of VT and, if the probe and other appliances are further refined, can reasonably be anticipated to be used as frequently as cryoablation.
